IP Library Granted Patent US 8,883,153
Granted Patent B2
US 8,883,153 · App. 13/260,664 · Granted Nov 11, 2014

Methods for preventing and treating angioedema

Inventor: Berhane Ghebrehiwet (Port Jefferson, NY)
Assignee: The Research for The State University of New York
A61K38/04C07K16/00C07K2317/76C07K7/18C07K7/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,153
App. No.
13/260,664
Granted
Nov 11, 2014
Kind
B2
Abstract

One aspect of the present invention provides a method of treating or preventing angioedema in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R. One aspect of the present invention provides a method of treating or preventing vascular permeability in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R.

Claims (6)

1. A method of treating angioedema in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R, wherein the agent binds to the HK binding site of gC1q-R or wherein the agent binds to a gC1q-R binding site of HK.

2. The method of claim 1 , wherein the agent comprises an antibody or polypeptide.

3. The method of claim 2 , wherein the agent is an antibody that binds to a HK-binding site of gC1q-R.

4. The method of claim 2 , wherein the antibody binds to a gC1q-R binding site of HK.

5. The method of claim 2 , wherein the agent is a polypeptide selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, and SEQ ID NO:16.

6. The method of claim 1 , wherein the patient is taking an ACE inhibitor.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PCT/US2010/029502 PREVIOUSLY RECORDED AT REEL: 035380 FRAME: 0242. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 8, 2015
From: BERHANE, GHEBREHIWET
To: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
Reel/Frame 037334/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2015
From: GHEBREHIWET, BERHANE
To: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
Reel/Frame 035380/0242 →
CONFIRMATORY LICENSE Recorded Nov 25, 2011
From: STATE UNIVERSITY NEW YORK STONY BROOK
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027281/0928 →
Continuity (2)
Provisional Application 61164197 · Mar 27, 2009
Related Publication 20120082676A1 · Apr 5, 2012